Partnering News

02.09.2021

Pfizer And Ida Foundation Partner To Expand Access To Essential Cancer Treatments In 70 Low-And Lower-Middle-Income Countries New Partnership Broadens Access To Oncology Treatments Across Latin America, Asia, Africa And The Western Pacific.

02.08.2021

Palleon Pharmaceuticals Appoints Nikola Trbovic to its Board of Directors

01.22.2021

Ten Leading BioPharma Companies Announce Formation of Accumulus Synergy to Develop Global Data Sharing Platform

01.21.2021

Cerevel Therapeutics Announces the Appointments of Deval Patrick and Deborah Baron to its Board of Directors

01.12.2021

Vedanta Biosciences Announces $25 Million Investment from Pfizer Inc.

01.12.2021

Pfizer Invests $120 Million in Biotechnology Innovation Through the Pfizer Breakthrough Growth Initiative

01.10.2021

Codex DNA Signs Early Access Collaboration and Licensing Agreement with Pfizer to FurtherDevelop CodexDNA’s Novel Enzymatic DNA Synthesis Technology for Pfizer’s use in its Research and Development ofmRNA-based Vaccines and Biotherapies

12.07.2020

PostEra enters a multi-year strategic partnership with Pfizer Inc. to advance machine learning for Drug Discovery

11.19.2020

Pfizer and LianBio Announce Strategic Collaboration to Expand Development of Novel Therapeutics in Greater China

11.09.2020

Homology Medicines Announces $60 Million Equity Investment from Pfizer Inc.

10.05.2020

SpringWorks Therapeutics Announces Clinical Collaboration with PfizerInc. to Evaluate Nirogacestat in Combination with PF‐06863135 in Patients with Relapsed or Refractory Multiple Myeloma

09.23.2020

Vivet Therapeutics and Pfizer Inc. Enter into Manufacturing Agreement for Vivet’s Investigational Gene Therapy for Wilson Disease